Meta-Analysishigh evidence

Optimal duration of dual antiplatelet therapy for secondary stroke prevention: A systematic review and meta-analysis.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·September 1, 2026·PMID 42218849

Why it matters

Understanding the temporal profile of DAPT’s benefits and risks can guide individualized treatment duration, potentially minimizing bleeding while preserving early ischemic protection in patients with minor stroke or high-risk TIA.

Infographic summary of Optimal duration of dual antiplatelet therapy for secondary stroke prevention: A systematic review and meta-analysis.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled